SCHEMBL4039869

SCHEMBL4039869

COc1ccccc1C1(C(C(=O)NC2CCCC2)C2CCCC2)Nc2ccccc2N1

nearest known ligand 0.48

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.45
ALDH1A1 P00352 2/20 0.45
ATM Q13315 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
RAB9A P51151 2/20 0.41
LMNA P02545 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TSHR P16473 2/20 0.40
NPC1 O15118 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4034357 0.91 HPGD (0.43) HPGDALDH1A1L3MBTL1RAB9ALMNA
SCHEMBL4037895 0.91 HPGD (0.43) HPGDALDH1A1L3MBTL1RAB9ALMNA
SCHEMBL4034697 0.88 MEN1 (0.48) ALDH1A1L3MBTL1RAB9ANPC1MEN1
SCHEMBL1577410 0.88 MEN1 (0.48) ALDH1A1L3MBTL1RAB9ANPC1MEN1
SCHEMBL4044757 0.88 MEN1 (0.48) ALDH1A1L3MBTL1RAB9ANPC1MEN1
SCHEMBL4040460 0.88 MEN1 (0.46) ALDH1A1L3MBTL1RAB9ANPC1MEN1
SCHEMBL4044158 0.87 GAA (0.47) HPGDALDH1A1RAB9ALMNATSHR
SCHEMBL4040899 0.87 KDM4E (0.47) HPGDALDH1A1TSHRMEN1KMT2A
SCHEMBL4037396 0.86 METAP2 (0.46) HPGDALDH1A1RAB9ALMNATSHR
SCHEMBL4041730 0.83 C3AR1 (0.46) HPGDALDH1A1LMNANPSR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed